PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

Europe’s SBA: A 30-year Career and Counting

May 18, 2022

The April 2022 biannual gathering of the European Sterile Barrier Association offered its industry professionals business-as-usual – familiar discussions of healthcare trends, sterile barrier packaging issues, and group work on a member project, yet there was...

Learn More

How to Approach Curving or Coiling Long Catheters

May 18, 2022

Long catheter systems can be a complicated problem when it comes to package design. As the name suggests, they are long and awkward to handle for manufacturing personnel, storage facilities, and end users. Considering alternative packaging configurations,...

Learn More

"Time is Brain" - A Lesson from Cath Lab Veterans

May 18, 2022

In our articles, we often focus on doctors and nurses, but there are so many people in other settings that support life changing procedures. This article is for them, with a specific focus on Registered Radiologic Technologists (RT), and the important role...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.